MedTrace Logo

IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism

NCT02945904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2025-03-10

No results posted yet for this study

Summary

Purpose of this clinical trial is to improve prediction of outcomes from surgical intervention in patients with Primary aldosteronism, and evaluate the merits of non-invasive metomidate PET CT versus adrenal vein sampling in the diagnosis of surgically correctable aldosteronism.

Conditions

  • Primary Aldosteronism
  • Hyperaldosteronism

Interventions

PROCEDURE

adrenalectomy

Unilateral adrenalectomy for Conn's adenoma

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • WBIC), Cambridge. University of Cambridge Addenbrookes Hospital, Cambridge CB2 2QQ

    collaborator UNKNOWN

  • Robertson Centre for Biostatistics University of Glasgow Glasgow G12 8QQ

    collaborator UNKNOWN

  • Barts and the London School of Medicine and Dentistry W Smithfield London - City of London EC1A 7BE

    collaborator UNKNOWN

  • Queen Mary University of London

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02945904 on ClinicalTrials.gov